October
25
 

Financial links to drug use guidelines

Many of the researchers and doctors who write the rules on prescribing drugs have financial connections to the manufacturers, according to an investigation by the leading journal Nature. More than one-third of authors declared that they had financial links to drug companies and more than 70% of clinical panels are affected. In one case, every member of a panel writing the guidelines for a treatment for anaemia for HIV patients had been paid by the drug's manufacturer. "The practice stinks," says Drummond Rennie, deputy editor of the Journal of the American Medical Association.

Although such links have been strongly criticised, the bodies which produce the guidelines counter that there simply aren't enough experts without potential conflicts of interest. The American Diabetes Association estimates that three-quarters of the members eligible to write clinical guidelines have conflicts of interest.


comments powered by Disqus
 

 Search BioEdge

 Subscribe to BioEdge newsletter
rss Subscribe to BioEdge RSS feed

 Best of the web

 Recent Posts
How can neuroethics combat ‘fake news’?
24 Jun 2017
Texas gives green-light for experimental stem-cell therapies
24 Jun 2017
CIA waterboarding was illegal human experimentation: report
24 Jun 2017
Should medics embed with Iraqi Army for safety?
24 Jun 2017
Going commercial with three-parent babies
24 Jun 2017

Home | About Us | Contact Us | rss RSS | Archive | Bookmark and Share | michael@bioedge.org

BioEdge - New Media Foundation Ltd © 2004 - 2009 All rights reserved -- Powered by Encyclomedia